John S. Parker, M.D., Major General (Ret.) Appointed Chairman
of ProtoKinetix' Science Advisory Board

Protokinetix Inc. (OTCBB:PKTX) President and CEO, Ross Senior, is pleased to announce the appointment of Dr. Parker as Chairman of ProtoKinetix’ Science Advisory Board as key to expanding the medical applications of the company’s anti-aging glycopeptides (AAGPs™) and optimizing their commercialization.

“Our top priority is delivering our technology into medical applications,” commented Senior. “This means having a structure and the right people in place, with a clear mandate and a visible role, who can perform on both the medical science and business fronts. The strategic significance of bringing Dr. Parker into a leadership position emphasizes our commitment to this objective.”

ProtoKinetix’ top business advisor Edward D. Martin, MD, Rear Admiral (Ret.) U.S. Public Health Service, concurred with Senior, “Bringing in a senior medical expert like John Parker to lead our Science Advisory Board has positive implications at several levels. As Chairman of the Business Advisory Board I enthusiastically look forward to working with Dr. Parker as we fully integrate our science with the commercialization of our anti-aging glycopeptides.”

Parker stated, “ProtoKinetix’ AAGP has tremendous potential for multiple applications in mainstream medical science as well as military health care delivery systems. I embrace the opportunity and challenge of helping bring this breakthrough technology to the forefront of biotech industry and government efforts in blood, cell and tissue preservation.”

Dr. Parker joined Science Applications International Corporation as Senior Vice President in 2002 and has achieved the entitlement to be designated as a Technical Fellow and serve as the Chief Medical Officer in the Health Solutions Unit. Immediately prior to joining SAIC he served 37 years of service with the United States Army. His last assignment was Commanding General, U.S. Army Medical Research and Materiel Command and the Fort Detrick Installation Commander. Dr. Parker was responsible for the Army’s medical research, product development, technology assessment, rapid prototyping, medical logistics management, health facility planning and medical information management and technology.

Dr. Parker received a doctorate in Medicine from Georgetown University of Medicine in 1974 and a bachelor’s degree in Biology, Philosophy and Journalism from Washington and Jefferson College in 1963. He is a diplomate of the American Board of Surgery and the American Board of Thoracic Surgery, a fellow of the American College of Surgeons and the American College of Chest Physicians, and a member of the American College of Physician Executives, Chairman of the Advisory board of the National Functional Genomics Center and has been appointed to the National Biodefense Science Board by the Secretary of Health and Human Services.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887